Solriamfetol Dose A

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)NCT07717892AXSMPhase 3Recruiting2028-06-30Estimated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)NCT07717879AXSMPhase 3Recruiting2028-06-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.